Preclinical and clinical studies into the bioactivity of low-dose naltrexone (LDN) for oncotherapy
Na Qu, Yiming Meng, Mike Handley, Chunyan Wang, Fengping Shan
Topics & Concepts
NaltrexonePharmacologyMedicineInternal medicineOpioidReceptorCancer, Stress, Anesthesia, and Immune ResponsePharmacological Receptor Mechanisms and EffectsNeuropeptides and Animal Physiology